A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma. - DeStefano, Vincent M; Wada, Masayuki; Pinz, Kevin G; Assi, Rita; Zhang, Hongyu; Wang, Weijia; Zhang, Wenli; Shah, Darshi; Ma, Yupo; Salman, Huda (Clinical & Translational Medicine, 2024)